Erratum: sanofi aventis grooms its ranks for biotech partnering
- Select a language for the TTS:
- UK English Female
- UK English Male
- US English Female
- US English Male
- Australian Female
- Australian Male
- Language selected: (auto detect) - EN
Play all audios:
_Nat. Biotechnol._ 27, 581–582 (2009); published online 8 July 2009; corrected after print 8 October 2009 In the version of this article initially published, the writer incorrectly states
that “BiPar was spun out of Genentech to develop small-molecule inhibitors....” The text should have read “BiPar was set up to develop small-molecule inhibitors....” The error has been
corrected in the HTML and PDF versions of the article. Authors * Nuala Moran View author publications You can also search for this author inPubMed Google Scholar ADDITIONAL INFORMATION The
online version of the original article can be found at 10.1038/nbt0709-581 RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Moran, N. Erratum: Sanofi
Aventis grooms its ranks for biotech partnering. _Nat Biotechnol_ 27, 957 (2009). https://doi.org/10.1038/nbt1009-957a Download citation * Issue Date: October 2009 * DOI:
https://doi.org/10.1038/nbt1009-957a SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not
currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative